Cholera medical therapy
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]
Overview
Overview
In most cases, cholera can be successfully treated with oral rehydration therapy (ORT), which is highly effective, safe, and simple to administer. In severe cases with significant dehydration, intravenous rehydration may be necessary. Ringer’s lactate is the preferred solution, often with added potassium. Large volumes and continued replacement until diarrhea has subsided may be needed[1][2]. Ten percent of a person’s body weight in fluid may need to be given in the first two to four hours. Antibiotic treatments for one to three days shorten the course of the disease and reduce the severity of the symptoms[3]. People can recover even without them, if sufficient hydration and electrolyte balance is maintained. Doxycycline is typically used first line[4], although some strains of V. cholerae have shown resistance[5]. Zinc supplementation has been shown to reduce stool output and reduces the duration and severity of symptoms.[6]
Medical Therapy
Medical Therapy
Summary of the Treatment
- Rehydrate with ORS or IV solution depending on the severity. Rehydration involves replenishment of the lost fluids and then maintenance of the fluid balance [1][2]
- Maintain hydration and monitor frequently the hydration status[1][2]
- Give antibiotics for severe cholera cases[7]
- Zinc supplementation for reduction of stool output and improvement of symptom duration and severity[6]
Management of Cholera Patients (table 1)
| Mental status | Eyes | Thirst | Skin pinch | Conclusions | Management |
|---|---|---|---|---|---|
| Normal, Alert | Normal, hydrated | Normal | Goes down quickly (spontaneously) | No / Mild dehydration |
|
| Irritable | Sunken | Drink eagerly | Goes back slowly (< 2 sec) | Some / Moderate dehydration (in case if 2 of the symptoms are present) |
|
| Lethargic, unconscious or floppy | Sunken, absence of tears | Drinks poorly | Goes back slowly (> 2 sec) | Severe dehydration (in case if 2 of the symptoms are present) |
Total amount per day: 200 ml/kg during the first 24 hours |
Management of Patients with Moderate Dehydration (table 2)
| Age | Less than 4 months | 4β11 months | 12β23 months | 2β4 years | 5β14 years | 15 years |
|---|---|---|---|---|---|---|
| Weight | Less than 5 kgs | 5β7.9 kg | 8β10.9 kg | 11β15.9 kg | 16β29.9 kg | 30 kg or more |
| ORS solution in ml | 200β400 | 400β600 | 600β800 | 800β1200 | 1200β2200 | 2200β4000 |
Maintenance of Hydration and Monitoring the Patient
Reassess the patient for signs of dehydration regularly during the first six hours:
- Number and quantity of stools and vomit in order to compensate for the loss of body fluids
- Radial pulse: if it remains weak, IV rehydration must be continued.
Method to Prepare Home-made Oral Rehydration Therapy Solution
Antibiotic regimen
Antibiotic regimen
-
- Note: Antibiotic treatment for cholera patients with severe dehydration only
- Adults
- Preferred regimen: Doxycycline 300 mg po single dose
- Alternative regimen: Tetracycline 12.5 mg/kg PO qid for 3 days
- Pediatric
- Under 12 years old
- Preferred regimen: Erythromycin 12.5 mg/kg PO qid for 3 days
- Over 12 years old
- Preferred regimen: Doxycycline 300 mg po single dose
- Alternative regimen: Tetracycline 12.5 mg/kg PO qid for 3 days
- 2. Pan American Health Organization [10]
- Note: Antibiotic treatment for cholera patients with moderate or severe dehydration
- 2.1 Adult
- Preferred regimen: Doxycycline 300 mg po single dose
- Alternative regimen (1): Ciprofloxacin 1 g PO single dose
- Alternative regimen (2): Azithromycin 1 g PO single dose
- 2.2 Pediatric
- 2.2.1 Children over 3 year, who can swallow tablets
- Preferred regimen (1): Erythromycin 12.5 mg/kg/ PO qid for 3 days
- Preferred regimen (2): Azithromycin 20 mg/kg PO in a single dose
- Alternative regimen (1): Ciprofloxacin suspension or tablets 20 mg/kg PO single dose
- Alternative regimen (2): Doxycycline suspension or tablets 2-4 mg/kg PO single dose
- Note: Although doxycycline has been associated with a low risk of yellowing of the teeth in children, its benefits outweigh its risks
- 2.2.2 Children under 3 year, or infants who cannot swallow tablets
- Preferred regimen (1): Erythromycin suspension 12.5 mg/kg/ PO qid for 3 days
- Preferred regimen (2): Azithromycin suspension 20 mg/kg PO single dose
- Alternative regimen (1): Ciprofloxacin suspension 20 mg/kg PO single dose
- Alternative regimen (2): Doxycycline syrup 2-4 mg/kg PO single dose
- 2.3 Pregnancy
- Preferred regimen (!): Erythromycin 500 mg/ PO qid for 3 days
- Preferred regimen (2): Azithromycin 1 g PO single dose
Nutrition
- Proper attention to nutrition is particularly important, as patients with cholera often ignore nutrition due to diarrhea and vomiting. This may lead to hypoglycemia and associated complications like seizure, coma, and even death in the pediatric population.
- Provide frequent small meals with familiar foods during the first two days rather than infrequent large meals.
- Breastfeeding of infants and young children should continue.
References
References
- β 1.0 1.1 1.2 Lankarani KB, Alavian SM (2013). “Lessons learned from past cholera epidemics, interventions which are needed today”. J Res Med Sci. 18 (8): 630β1. PMCΒ 3872598. PMIDΒ 24379835.
- β 2.0 2.1 2.2 Hahn S, Kim S, Garner P (2002). “Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children”. Cochrane Database Syst Rev (1): CD002847. doi:10.1002/14651858.CD002847. PMIDΒ 11869639.
- β Kabir I, Khan WA, Haider R, Mitra AK, Alam AN (1996). “Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children”. J Diarrhoeal Dis Res. 14 (4): 243β7. PMIDΒ 9203786.
- β Sack DA, Islam S, Rabbani H, Islam A (1978). “Single-dose doxycycline for cholera”. Antimicrob Agents Chemother. 14 (3): 462β4. PMCΒ 352482. PMIDΒ 708024.
- β Towner KJ, Pearson NJ, Mhalu FS, O’Grady F (1980). “Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania”. Bull World Health Organ. 58 (5): 747β51. PMCΒ 2395989. PMIDΒ 6975183.
- β 6.0 6.1 Roy SK, Hossain MJ, Khatun W, Chakraborty B, Chowdhury S, Begum A; et al. (2008). “Zinc supplementation in children with cholera in Bangladesh: randomised controlled trial”. BMJ. 336 (7638): 266β8. doi:10.1136/bmj.39416.646250.AE. PMCΒ 2223005. PMIDΒ 18184631.
- β Nelson EJ, Nelson DS, Salam MA, Sack DA (2011). “Antibiotics for both moderate and severe cholera”. N Engl J Med. 364 (1): 5β7. doi:10.1056/NEJMp1013771. PMIDΒ 21142691.
- β “WHO. Cholera Outbreak: Assessing the Outbreak Response and Improving Preparedness” (PDF).
- β “Prevention and control of cholera outbreaks: WHO policy and recommendations”.
- β [file:///Users/censhanshan/Desktop/cholera_clin_management_ENG_rev_JUN%201.pdf “PAHO. Recommendations for clinical management of cholera”] Check
|url=value (help) (PDF).
Looking for the patient version?
Β© 2026 MyEClinic β IFTM Institut fΓΌr Telematik in der Medizin GmbH
